{"id":"https://openalex.org/W4417011663","doi":"https://doi.org/10.1182/blood-2025-790","title":"Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes","display_name":"Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W4417011663","doi":"https://doi.org/10.1182/blood-2025-790"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2025-790","doi":"https://doi.org/10.1182/blood-2025-790","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2025-790","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007194601","display_name":"Lalit Saini","orcid":"https://orcid.org/0000-0003-3104-106X","observed_orcids":["https://orcid.org/0000-0003-3104-106X"]},"institutions":[{"id":"https://openalex.org/I2800925808","display_name":"London Health Sciences Centre","ror":"https://ror.org/037tz0e16","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800925808"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lalit Saini","raw_affiliation_strings":["2London Health Sciences Centre, London, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2London Health Sciences Centre, London, Canada","institution_ids":["https://openalex.org/I2800925808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067521829","display_name":"Amer Methqal Zeidan","orcid":"https://orcid.org/0000-0001-7017-8160","observed_orcids":["https://orcid.org/0000-0001-7017-8160"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amer Zeidan","raw_affiliation_strings":["3Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071257161","display_name":"Abdulraheem Yacoub","orcid":"https://orcid.org/0000-0001-5293-4620","observed_orcids":["https://orcid.org/0000-0001-5293-4620"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdulraheem Yacoub","raw_affiliation_strings":["4University of Kansas Medical Center, Hematologic Malignancies and Cellular Therapeutics, Kansas, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Kansas Medical Center, Hematologic Malignancies and Cellular Therapeutics, Kansas, United States","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049440929","display_name":"Lori J. Maness","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307117695","display_name":"Nebraska Medical Center","ror":"https://ror.org/03azxga02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1307117695"]},{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Maness","raw_affiliation_strings":["5University of Nebraska Medical Center, Division of Hematology-Oncology, Department of Internal Medicine, Omaha, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University of Nebraska Medical Center, Division of Hematology-Oncology, Department of Internal Medicine, Omaha, United States","institution_ids":["https://openalex.org/I1307117695","https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005105433","display_name":"Elie A. Traer","orcid":"https://orcid.org/0000-0001-8844-2345","observed_orcids":["https://orcid.org/0000-0001-8844-2345"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elie Traer","raw_affiliation_strings":["6Oregon Health & Science University, Knight Cancer Institute, Portland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Oregon Health & Science University, Knight Cancer Institute, Portland, United States","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035051206","display_name":"James M. Foran","orcid":"https://orcid.org/0000-0003-1673-1708","observed_orcids":["https://orcid.org/0000-0003-1673-1708"]},"institutions":[{"id":"https://openalex.org/I4390039324","display_name":"Mayo Clinic Comprehensive Cancer Center (Florida)","ror":"https://ror.org/007q04248","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710","https://openalex.org/I4390039324"]}],"countries":[],"is_corresponding":false,"raw_author_name":"James Foran","raw_affiliation_strings":["7Mayo Clinic Comprehensive Cancer Center, Jacksonville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Mayo Clinic Comprehensive Cancer Center, Jacksonville, United States","institution_ids":["https://openalex.org/I4390039324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051485142","display_name":"Sanjay Ram Mohan","orcid":"https://orcid.org/0000-0002-6715-6697","observed_orcids":["https://orcid.org/0000-0002-6715-6697"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjay Mohan","raw_affiliation_strings":["8Vanderbilt-Ingram Cancer Center, Nashville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Vanderbilt-Ingram Cancer Center, Nashville, United States","institution_ids":["https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047951694","display_name":"Michael L\u00fcbbert","orcid":"https://orcid.org/0000-0003-1186-1650","observed_orcids":["https://orcid.org/0000-0003-1186-1650"]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]},{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael L\u00fcbbert","raw_affiliation_strings":["9Medical Center\u2014University of Freiburg, Department of Hematology, Oncology and Stem Cell Transplantation, Freiberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Medical Center\u2014University of Freiburg, Department of Hematology, Oncology and Stem Cell Transplantation, Freiberg, Germany","institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017347796","display_name":"Tom Lodewyck","orcid":"https://orcid.org/0000-0002-7570-0656","observed_orcids":["https://orcid.org/0000-0002-7570-0656"]},"institutions":[{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Tom Lodewyck","raw_affiliation_strings":["10AZ St-Jan Brugge-Oostende Hospital, Department of Hematology, Bruges, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10AZ St-Jan Brugge-Oostende Hospital, Department of Hematology, Bruges, Belgium","institution_ids":["https://openalex.org/I4210123377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067159029","display_name":"Blanca Xicoy","orcid":"https://orcid.org/0000-0002-0295-1307","observed_orcids":["https://orcid.org/0000-0002-0295-1307"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Blanca Xicoy","raw_affiliation_strings":["11Hospital Germans Trias I Pujol, Institut Catal\u00e0 Oncologia, Josep Carreras Leukemia Research Institute, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Hospital Germans Trias I Pujol, Institut Catal\u00e0 Oncologia, Josep Carreras Leukemia Research Institute, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210089592","https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111734860","display_name":"Harshad Amin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134076","display_name":"BRCR Global (United States)","ror":"https://ror.org/0360x1161","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134076"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harshad Amin","raw_affiliation_strings":["12Boca Raton Clinical Research, Global, Plantation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Boca Raton Clinical Research, Global, Plantation, United States","institution_ids":["https://openalex.org/I4210134076"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022965758","display_name":"Kimo Bachiashvili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimo Bachiashvili","raw_affiliation_strings":["13University of Alabama at Birmingham, Division of Hematology and Oncology, Department of Medicine, Birmingham, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13University of Alabama at Birmingham, Division of Hematology and Oncology, Department of Medicine, Birmingham, United States","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024431512","display_name":"Habte Aragaw Yimer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Habte Yimer","raw_affiliation_strings":["14Texas Oncology-Tyler/US Oncology Research, Tyler, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Texas Oncology-Tyler/US Oncology Research, Tyler, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110803392","display_name":"Nancy Yan Zhu","orcid":"https://orcid.org/0009-0009-4270-1570","observed_orcids":["https://orcid.org/0009-0009-4270-1570"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Nancy Zhu","raw_affiliation_strings":["15University of Alberta, Edmonton, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15University of Alberta, Edmonton, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069175","display_name":"Haifa Kathrin Al\u2010Ali","orcid":"https://orcid.org/0000-0001-5009-2239","observed_orcids":["https://orcid.org/0000-0001-5009-2239"]},"institutions":[{"id":"https://openalex.org/I68956291","display_name":"Martin Luther University Halle-Wittenberg","ror":"https://ror.org/05gqaka33","country_code":"DE","type":"education","lineage":["https://openalex.org/I68956291"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Haifa Kathrin Al-Ali","raw_affiliation_strings":["16Krukenberg Cancer Center Halle, Martin Luther University Halle-Wittenberg, University Medicine Halle, Halle (Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Krukenberg Cancer Center Halle, Martin Luther University Halle-Wittenberg, University Medicine Halle, Halle (Saale), Germany","institution_ids":["https://openalex.org/I68956291"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Patricia Font Lopez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4405268975","display_name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/02p8e3h61","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268975"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Patricia Font Lopez","raw_affiliation_strings":["17Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM), Madrid, Spain","institution_ids":["https://openalex.org/I2960094004","https://openalex.org/I4405268975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052934298","display_name":"Guillermo Francisco Sanz","orcid":"https://orcid.org/0000-0002-2767-8191","observed_orcids":["https://orcid.org/0000-0002-2767-8191"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Guillermo Sanz","raw_affiliation_strings":["18Hospital Universitario y Polit\u00e9cnico La Fe, Department of Haematology, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Hospital Universitario y Polit\u00e9cnico La Fe, Department of Haematology, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091318797","display_name":"Valeria Santini","orcid":"https://orcid.org/0000-0002-5439-2172","observed_orcids":["https://orcid.org/0000-0002-5439-2172"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Santini","raw_affiliation_strings":["19University of Florence, MDS Unit, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19University of Florence, MDS Unit, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050961257","display_name":"Jes\u00fas G. Berdeja","orcid":"https://orcid.org/0000-0003-4362-0376","observed_orcids":["https://orcid.org/0000-0003-4362-0376"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jes\u00fas Berdeja","raw_affiliation_strings":["20Tennessee Oncology, Nashville, Nashville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Tennessee Oncology, Nashville, Nashville, United States","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053965953","display_name":"Victor M. Priego","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129209","display_name":"Center for Cancers and Blood Disorders","ror":"https://ror.org/03jh7ct92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210129209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Priego","raw_affiliation_strings":["21The Center for Cancer and Blood Disorders, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21The Center for Cancer and Blood Disorders, Bethesda, United States","institution_ids":["https://openalex.org/I4210129209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060015628","display_name":"Olatoyosi M. Odenike","orcid":"https://orcid.org/0000-0002-4027-4124","observed_orcids":["https://orcid.org/0000-0002-4027-4124"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olatoyosi Odenike","raw_affiliation_strings":["22The University of Chicago, Chicago, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22The University of Chicago, Chicago, United States","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102956328","display_name":"Bert Heyrman","orcid":"https://orcid.org/0000-0001-5816-5375","observed_orcids":["https://orcid.org/0000-0001-5816-5375","https://orcid.org/0000-0002-3900-4426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bert Heyrman","raw_affiliation_strings":["23Ziekenhuis Netwerk Antwerpen, Department of Haematology, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"23Ziekenhuis Netwerk Antwerpen, Department of Haematology, Antwerp, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020211212","display_name":"David Valc\u00e1rcel","orcid":"https://orcid.org/0000-0002-8747-078X","observed_orcids":["https://orcid.org/0000-0002-8747-078X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Valcarcel","raw_affiliation_strings":["24Hospital Universitario Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"24Hospital Universitario Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yubing Wan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yubing Wan","raw_affiliation_strings":["25Taiho Oncology, Inc, Pleasanton, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"25Taiho Oncology, Inc, Pleasanton, United States","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058326151","display_name":"Winny Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Winny Chan","raw_affiliation_strings":["25Taiho Oncology, Inc, Pleasanton, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"25Taiho Oncology, Inc, Pleasanton, United States","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001745177","display_name":"Aram Oganesian","orcid":"https://orcid.org/0000-0001-5358-743X","observed_orcids":["https://orcid.org/0000-0001-5358-743X"]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aram Oganesian","raw_affiliation_strings":["25Taiho Oncology, Inc, Pleasanton, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"25Taiho Oncology, Inc, Pleasanton, United States","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110021104","display_name":"Yuri Sano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuri Sano","raw_affiliation_strings":["25Taiho Oncology, Inc, Pleasanton, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"25Taiho Oncology, Inc, Pleasanton, United States","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036678244","display_name":"Harold N Keer","orcid":"https://orcid.org/0000-0003-0753-4921","observed_orcids":["https://orcid.org/0000-0003-0753-4921"]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harold Keer","raw_affiliation_strings":["25Taiho Oncology, Inc, Pleasanton, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"25Taiho Oncology, Inc, Pleasanton, United States","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060452476","display_name":"Elizabeth A. Griffiths","orcid":"https://orcid.org/0000-0002-0288-8248","observed_orcids":["https://orcid.org/0000-0002-0288-8248"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Griffiths","raw_affiliation_strings":["26Roswell Park Comprehensive Cancer Center, Buffalo, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"26Roswell Park Comprehensive Cancer Center, Buffalo, United States","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":30,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Supplement 1","first_page":"790","last_page":"790"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lower-risk-myelodysplastic-syndromes","display_name":"lower-risk myelodysplastic syndromes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cedazuridine","display_name":"cedazuridine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9129999876022339},{"id":"https://openalex.org/keywords/low-dose-regimen","display_name":"low-dose regimen","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8759999871253967},{"id":"https://openalex.org/keywords/leukemia-free-survival","display_name":"leukemia-free survival","score":0.8769999742507935},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cytopenia","display_name":"cytopenia","score":0.4950000047683716},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion-dependence","display_name":"red blood cell transfusion dependence","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9035999774932861},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8639000058174133},{"id":"https://openalex.org/C2780366003","wikidata":"https://www.wikidata.org/wiki/Q246147","display_name":"Cytopenia","level":3,"score":0.8274000287055969},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7591000199317932},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6754999756813049},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.6674000024795532},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6017000079154968},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5983999967575073},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5708000063896179},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4781999886035919},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4706000089645386},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45159998536109924},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4472000002861023},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.40610000491142273},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.392300009727478},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.38510000705718994},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3806999921798706},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.37059998512268066},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.36800000071525574},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3628000020980835},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.3481000065803528},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3328000009059906},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.31470000743865967},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.30809998512268066},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30250000953674316},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.27959999442100525},{"id":"https://openalex.org/C2776581026","wikidata":"https://www.wikidata.org/wiki/Q864868","display_name":"Bone marrow suppression","level":3,"score":0.2676999866962433},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.2624000012874603},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C2779316324","wikidata":"https://www.wikidata.org/wiki/Q212272","display_name":"Hydroxycarbamide","level":3,"score":0.25609999895095825},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.25519999861717224}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2025-790","doi":"https://doi.org/10.1182/blood-2025-790","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2025-790","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Parenteral":[2],"DNA":[3],"methyltransferase":[4],"inhibitors":[5],"(DNMTi)":[6],"such":[7],"as":[8,121,687],"azacitidine":[9],"and":[10,61,78,96,103,149,171,227,245,258,262,273,292,298,306,337,387,408,419,425,428,441,462,491,520,531,538,550,571,595,619,672,678],"decitabine":[11],"(DEC),":[12],"including":[13,674],"an":[14],"attenuated":[15,135],"3-day":[16],"regimen,":[17],"are":[18],"recommended":[19],"in":[20,105,363,374,405,448,459,473,481,495,529,535,548,580,584,597,603,615,622],"the":[21,122,134,269,364,375,496,512,536,581,585,598,616,623,631,638],"NCCN":[22],"Guidelines":[23],"for":[24,627,692],"patients":[25],"(pts)":[26],"with":[27,32,107,133,158,511,648,669,694],"lower-risk":[28],"myelodysplastic":[29],"syndromes":[30],"(LR-MDS)":[31],"clinically":[33],"significant":[34],"cytopenias.":[35],"However,":[36],"parenteral":[37],"administration":[38],"requires":[39],"frequent":[40],"clinic":[41],"visits,":[42],"which":[43,588,606],"imposes":[44],"a":[45,70,85,112,247,344,436,471,477,516,688],"substantial":[46],"burden":[47],"on":[48,145,252],"pts,":[49,264,416,553],"particularly":[50],"those":[51],"requiring":[52],"long-term":[53],"therapy.":[54],"Oral":[55,66],"DMTIs":[56],"offer":[57],"more":[58,486,493,517],"flexible":[59],"dosing":[60],"maintenance":[62],"of":[63,99,115,231,249,347,411,438,454,465,533,552,630,637],"pts'":[64],"autonomy.":[65],"DEC-cedazuridine":[67],"(DEC-C)":[68],"is":[69,84],"fixed-dose":[71],"combination":[72],"tablet":[73],"containing":[74],"DEC":[75,116],"(35":[76,196],"mg)":[77],"cedazuridine":[79],"(100":[80],"mg).":[81],"ASTX727-03":[82],"(NCT03502668)":[83],"randomized,":[86],"open-label,":[87],"multicenter,":[88],"phase":[89,142],"1/2":[90],"clinical":[91,663],"trial":[92,697],"evaluating":[93],"safety,":[94,147],"efficacy,":[95,146],"pharmacokinetics":[97],"(PK)":[98],"various":[100],"DEC-C":[101,187,660,686],"doses":[102],"regimens":[104,469],"pts":[106,236,276,534,693],"LR-MDS.":[108,695],"Phase":[109,127],"1":[110,328,596],"identified":[111],"5-day":[113],"regimen":[114,132,691],"10":[117,439],"mg/cedazuridine":[118],"100":[119],"mg":[120,190,197],"optimized":[123],"low-dose":[124],"(LD)":[125,291,297,407,418,427,440,450,461],"regimen.":[126,138],"2":[128,143,333,583],"compares":[129],"this":[130],"LD":[131,188,261,365,513,537,586,617,632,649,658,685],"standard-dose":[136],"(SD)":[137,294,300,410,421,430,443,453,464],"Here,":[139],"we":[140],"report":[141],"results":[144],"PK,":[148,210],"pharmacodynamic":[150],"(PD)":[151],"data.":[152],"Methods:":[153],"Adults":[154],"(aged":[155],"\u226518":[156],"years)":[157],"International":[159,398],"Prognostic":[160],"Scoring":[161],"System":[162],"(IPSS)":[163],"low-risk":[164],"or":[165,174,194,317,506],"Intermediate-1":[166],"MDS,":[167],"ECOG":[168],"PS":[169],"0\u22122,":[170],"\u22651":[172],"cytopenia":[173],"red":[175],"blood":[176,474],"cell":[177,285],"(RBC)":[178],"transfusion":[179],"dependence":[180],"were":[181,237,266,560,589],"randomized":[182],"1:1":[183],"to":[184,216,282,545,592,665],"receive":[185],"oral":[186,659,667],"(10":[189],"x":[191,198],"5":[192],"days)":[193],"SD":[195,242,263,376,497,539,599,624,639,666],"3":[199,339],"days).":[200],"The":[201],"primary":[202],"endpoint":[203],"was":[204,289,325,352,380,403,485,492,607,612,634,646],"hematologic":[205],"response.":[206],"Secondary":[207],"endpoints":[208],"included":[209],"PD":[211],"(by":[212],"LINE-1":[213,643],"demethylation),":[214],"time":[215],"bone":[217],"marrow":[218],"blasts":[219],">5%,":[220],"leukemia-free":[221],"survival":[222,225],"(LFS),":[223],"overall":[224],"(OS),":[226],"safety.":[228],"Results:":[229],"As":[230],"October":[232],"31,":[233],"2024,":[234],"81":[235],"treated":[238],"(LD":[239],"arm:":[240,243],"n=40;":[241],"n=41)":[244],"completed":[246],"median":[248,345,350,437],"8.8":[250],"months":[251,354,369,382,389],"treatment.":[253],"At":[254],"cutoff,":[255],"17":[256],"(42.5%)":[257],"12":[259],"(28.6%)":[260],"respectively,":[265,277],"still":[267],"continuing":[268],"study;":[270],"9":[271,442],"(22.5%)":[272],"6":[274],"(14.6%)":[275],"had":[278,301,310],"discontinued":[279],"treatment":[280,468,542,608],"due":[281,544],"hematopoietic":[283],"stem":[284],"transplant.":[286],"Median":[287,378],"age":[288],"70":[290],"75":[293],"years;":[295],"75.0%":[296],"68.3%":[299],"IPSS":[302],"Int-1":[303],"risk":[304,323],"MDS":[305,313],"60.0%":[307],"vs":[308,330,335,341,367,451],"41.5%":[309],"IPSS-Molecular":[311],"Lower-Risk":[312],"(very":[314],"low,":[315,316],"moderate-low).":[318],"Low-risk":[319],"prognostic":[320],"scoring":[321],"system":[322],"distribution":[324],"similar:":[326],"Category":[327,332,338],"(2.5%":[329],"4.9%),":[331],"(47.5%":[334],"46.3%),":[336],"(50.0%":[340],"48.8%).":[342],"After":[343],"follow-up":[346],"29.3":[348],"months,":[349],"OS":[351],"23.9":[353],"(95%":[355,370,383,390],"confidence":[356],"interval":[357],"[CI]:":[358],"13.0,":[359,385],"not":[360],"estimable":[361],"[NE])":[362],"arm":[366,600,618,633],"26.0":[368],"CI:":[371,384,391],"19.4,":[372],"28.5)":[373],"arm.":[377,498,640],"LFS":[379],"23.8":[381],"NE)":[386],"25.7":[388],"17.8,":[392],"26.5),":[393],"respectively.":[394,554],"Hematologic":[395],"improvement":[396],"per":[397],"Working":[399],"Group":[400],"2006":[401],"criteria":[402],"achieved":[404,422,431],"27.5%":[406],"26.8%":[409],"pts.":[412,466],"Among":[413],"RBC":[414],"transfusion\u2013dependent":[415],"52.4%":[417],"37.5%":[420],"\u226556-day":[423],"independence":[424],"47.6%":[426],"20.8%":[429],"\u2265112-day":[432],"independence.":[433],"Pts":[434],"received":[435],"cycles.":[444],"Delayed":[445],"cycles":[446,490,510,629],"occurred":[447,458,528,547,579],"72.5%":[449],"82.9%":[452],"pts;":[455],"dose":[456,676],"reductions":[457],"40.0%":[460],"46.3%":[463],"Both":[467],"caused":[470],"decrease":[472],"counts,":[475],"reaching":[476],"nadir":[478],"before":[479],"recovering":[480],"each":[482],"cycle.":[483],"Neutropenia":[484],"pronounced":[487],"during":[488],"early":[489],"severe":[494,680],"Blood":[499],"counts":[500],"across":[501],"all":[502,628],"lineages":[503],"remained":[504],"stable":[505],"improved":[507,670],"through":[508],"\u226512":[509],"arm,":[514,587],"suggesting":[515],"favorable":[518],"safety":[519,671],"tolerability":[521],"profile.":[522],"Grade":[523],"\u22653":[524],"adverse":[525],"events":[526],"(AEs)":[527],"85.0%":[530],"90.2%":[532],"arms,":[540],"respectively;":[541],"discontinuation":[543],"AEs":[546,559],"2.5%":[549],"17.1%":[551],"Most":[555],"commonly":[556],"reported":[557],"treatment-emergent":[558],"anemia":[561],"(42.5%":[562],"LD,":[563,568,574],"39.0%":[564,575],"SD),":[565,570],"fatigue":[566],"(32.5%":[567],"43.9%":[569],"thrombocytopenia":[572],"(37.5%":[573],"SD).":[576],"Three":[577],"deaths":[578],"trial:":[582],"both":[590],"unrelated":[591],"study":[593],"treatment,":[594],"(Pseudomonal":[601],"bacteremia":[602],"Cycle":[604,655],"1),":[605],"related.":[609],"Total":[610],"AUC0\u201324":[611],"199":[613],"ng*h/mL":[614,621],"465":[620],"arm;":[625],"AUC":[626],"approximately":[635],"half":[636],"Maximal":[641],"%":[642],"demethylation":[644],"rate":[645],"lower":[647],"than":[650],"SD,":[651],"but":[652],"narrowed":[653],"by":[654],"3.":[656],"Conclusion:":[657],"demonstrated":[661],"comparable":[662],"benefit":[664],"DEC-C,":[668],"tolerability,":[673],"fewer":[675],"modifications":[677],"less":[679],"myelosuppression.":[681],"These":[682],"findings":[683],"support":[684],"potential":[689],"optimal":[690],"Clinical":[696],"registration:":[698],"NCT03502668":[699]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-12-04T00:00:00"}